Corrigendum to "Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity" [Biochem. Biophys. Res. Commun. 501 (1) (18 June 2018) 124-130].

Autor: Luczynski MT; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Harrison PT; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Lima N; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Krasny L; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Paul A; Proteomics Core Facility, The Institute of Cancer Research, London, United Kingdom., Huang PH; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. Electronic address: paul.huang@icr.ac.uk.

Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2018 Sep 26; Vol. 504 (1), pp. 360. Date of Electronic Publication: 2018 Aug 22.

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors.

Autor: Wong JP; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Todd JR; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Finetti MA; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE1 4LP, UK., McCarthy F; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Broncel M; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Vyse S; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Luczynski MT; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Crosier S; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE1 4LP, UK., Ryall KA; Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Holmes K; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Payne LS; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK., Daley F; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK., Wai P; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK., Jenks A; Division of Cancer Therapeutics, The Institute of Cancer Research, London SW3 6JB, UK., Tanos B; Division of Cancer Therapeutics, The Institute of Cancer Research, London SW3 6JB, UK., Tan AC; Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Natrajan RC; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK., Williamson D; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE1 4LP, UK., Huang PH; Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: paul.huang@icr.ac.uk.

Publikováno v: Cell reports [Cell Rep] 2016 Oct 25; Vol. 17 (5), pp. 1265-1275.

Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining.

Autor: Cook R; Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; Cancer Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK., Zoumpoulidou G; Cancer Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK., Luczynski MT; Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK., Rieger S; Cancer Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK., Moquet J; Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot OX11 0RQ, UK., Spanswick VJ; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK., Hartley JA; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK., Rothkamm K; Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot OX11 0RQ, UK., Huang PH; Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. Electronic address: paul.huang@icr.ac.uk., Mittnacht S; Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; Cancer Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK. Electronic address: s.mittnacht@ucl.ac.uk.

Publikováno v: Cell reports [Cell Rep] 2015 Mar 31; Vol. 10 (12), pp. 2006-18. Date of Electronic Publication: 2015 Mar 26.

Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants.

Autor: Iwai LK; Protein Networks Team, Division of Cancer Biology, Institute of Cancer Research, London SW3 6JB, UK., Payne LS, Luczynski MT, Chang F, Xu H, Clinton RW, Paul A, Esposito EA, Gridley S, Leitinger B, Naegle KM, Huang PH

Publikováno v: The Biochemical journal [Biochem J] 2013 Sep 15; Vol. 454 (3), pp. 501-13.